Stay updated with breaking news from Actavis Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/STIWFCDJCFLSTG4OXLWBM442SQ.jpg)
Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease drug Neupro, clearing an obstacle for Teva's Actavis Laboratories UT Inc and Viatris' Mylan Technologies Inc to sell generic versions of the drug.
By Blake Brittain (Reuters) - Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Pa...
R&B singer and Pryor Cashman client Chris Brown settled a lawsuit brought by Greensleeves Publishing claiming that Brown's single "Privacy" copied parts of another song.
/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated pharmaceutical company with a robust portfolio of CNS products announced that the U.S. Court of...